These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


332 related items for PubMed ID: 2910421

  • 1. A comparison of two regimens for high-risk acute lymphocytic leukemia in childhood. A Pediatric Oncology Group Study.
    van Eys J, Berry D, Crist W, Doering E, Fernbach D, Pullen J, Shuster J, Wharam M.
    Cancer; 1989 Jan 01; 63(1):23-9. PubMed ID: 2910421
    [Abstract] [Full Text] [Related]

  • 2. Repetitive low dose oral methotrexate and intravenous mercaptopurine treatment for patients with lower risk B-lineage acute lymphoblastic leukemia. A Pediatric Oncology Group pilot study.
    Mahoney DH, Camitta BM, Leventhal BG, Shuster JJ, Civin CJ, Ganick DJ, Lauer SJ, Steuber CP, Kamen BA.
    Cancer; 1995 May 15; 75(10):2623-31. PubMed ID: 7736409
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. Equivalence of intrathecal chemotherapy and radiotherapy as central nervous system prophylaxis in children with acute lymphatic leukemia: a pediatric oncology group study.
    Sullivan MP, Chen T, Dyment PG, Hvizdala E, Steuber CP.
    Blood; 1982 Oct 15; 60(4):948-58. PubMed ID: 6956376
    [Abstract] [Full Text] [Related]

  • 7. Current results of studies of immunophenotype-, age- and leukocyte-based therapy for children with acute lymphoblastic leukemia. The Pediatric Oncology Group.
    Crist W, Shuster J, Look T, Borowitz M, Behm F, Bowman P, Frankel L, Pullen J, Krance R, Steuber P.
    Leukemia; 1992 Oct 15; 6 Suppl 2():162-6. PubMed ID: 1578922
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Adult acute lymphoblastic leukemia: results of an aggressive regimen in India.
    Raje N, Pai S, Vaidya S, Gopal R, Parikh P, Saikia T, Pai V, Nadkarni K, Advani IM.
    Leuk Lymphoma; 1994 Jul 15; 14(3-4):285-90. PubMed ID: 7950917
    [Abstract] [Full Text] [Related]

  • 10. Value of high-dose cytarabine during interval therapy of a Berlin-Frankfurt-Munster-based protocol in increased-risk children with acute lymphoblastic leukemia and lymphoblastic lymphoma: results of the European Organization for Research and Treatment of Cancer 58881 randomized phase III trial.
    Millot F, Suciu S, Philippe N, Benoit Y, Mazingue F, Uyttebroeck A, Lutz P, Mechinaud F, Robert A, Boutard P, Marguerite G, Ferster A, Plouvier E, Rialland X, Behard C, Plantaz D, Dresse MF, Philippet P, Norton L, Thyss A, Dastugue N, Waterkeyn C, Vilmer E, Otten J, Children's Leukemia Cooperative Group of the European Organiztaion for Research and Treatment of Cancer.
    J Clin Oncol; 2001 Apr 01; 19(7):1935-42. PubMed ID: 11283125
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Novel multiagent chemotherapy for bone marrow relapse of pediatric acute lymphoblastic leukemia.
    Leahey AM, Bunin NJ, Belasco JB, Meek R, Scher C, Lange BJ.
    Med Pediatr Oncol; 2000 May 01; 34(5):313-8. PubMed ID: 10797352
    [Abstract] [Full Text] [Related]

  • 16. Three versus five years of maintenance therapy are equivalent in childhood acute lymphoblastic leukemia: a report from the Childrens Cancer Study Group.
    Miller DR, Leikin SL, Albo VC, Sather H, Hammond GD.
    J Clin Oncol; 1989 Mar 01; 7(3):316-25. PubMed ID: 2645385
    [Abstract] [Full Text] [Related]

  • 17. Effectiveness of intensified rotational combination chemotherapy for late hematologic relapse of childhood acute lymphoblastic leukemia.
    Rivera GK, Hudson MM, Liu Q, Benaim E, Ribeiro RC, Crist WM, Pui CH.
    Blood; 1996 Aug 01; 88(3):831-7. PubMed ID: 8704238
    [Abstract] [Full Text] [Related]

  • 18. [The efficacy of BFM-90 program in the treatment of acute lymphoblastic leukemia in children in the studies of Polish pediatric leukemia/lymphoma group].
    Chybicka A, Bogusławska-Jaworska J, Gorczyńska E, Juszczak K, Armata J, Balcerska A, Balwierz W, Bubała H, Filiks-Litwin B, Kołecki P, Kowalczyk J, Lukowska K, Matysiak M, Rokicka-Milewska R, Rola-Kurc E, Stencel D, Sońta-Jakimczyk D, Strojny W, Wachowiak J, Wieczorek M, Wysocki M, Zelenay E.
    Wiad Lek; 1998 Aug 01; 51 Suppl 4():25-32. PubMed ID: 10731940
    [Abstract] [Full Text] [Related]

  • 19. Intensive BFM chemotherapy for childhood ALL: interim analysis of the AIEOP-ALL 91 study. Associazione Italiana Ematologia Oncologia Pediatrica.
    Conter V, Aricò M, Valsecchi MG, Rizzari C, Testi A, Miniero R, Di Tullio MT, Lo Nigro L, Pession A, Rondelli R, Messina C, Santoro N, Mori PG, De Rossi G, Tamaro P, Silvestri D, Biondi A, Basso G, Masera G.
    Haematologica; 1998 Sep 01; 83(9):791-9. PubMed ID: 9825576
    [Abstract] [Full Text] [Related]

  • 20. Treatment of occult or late overt testicular relapse in children with acute lymphoblastic leukemia: a Pediatric Oncology Group study.
    Wofford MM, Smith SD, Shuster JJ, Johnson W, Buchanan GR, Wharam MD, Ritchey AK, Rosen D, Haggard ME, Golembe BL.
    J Clin Oncol; 1992 Apr 01; 10(4):624-30. PubMed ID: 1548525
    [Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 17.